BPA FOR PLUVICTO AND LUTATHERA INJECTION

Contract Award won by NOVARTIS PHARMACEUTICALS CORPORATION
No current value reported
RecipientNOVARTIS PHARMACEUTICALS CORPORATION UEI NG61ZA8TADW3
Award IDHT941026AE002
Award amountNo current value reported
Award type—
Awarding agencyDepartment of Defense — Defense Health Agency
NAICS325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
PSC6505
Start dateMar 2, 2026
End date—
Place of performance—
Record updatedFeb 9, 2026

View the official award record

More awards won by NOVARTIS PHARMACEUTICALS CORPORATION

ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF
Department of Health and Human Services · $16,334,775 · Sep 14, 2017
CLIN 2001AA AND CLIN 2001AB
Department of Defense · $5,369,485 · Oct 1, 2026
PLUVICTO
Department of Veterans Affairs · $4,732,608 · Feb 24, 2026
PLUVICTO AND LUTATHERA
Department of Veterans Affairs · $4,299,447 · Nov 1, 2025
LU177 - PLUVICTO/LUTATHERA
Department of Veterans Affairs · $4,162,659 · Feb 7, 2026

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids